Literature DB >> 11411831

Human West Nile virus surveillance--Connecticut, New Jersey, and New York, 2000.

.   

Abstract

West Nile virus (WNV), a mosquitoborne arbovirus identified in New York in 1999, has become enzootic in the northeastern United States, affecting humans, birds, horses, and other mammals. Although no human WNV infection was identified in Connecticut or New Jersey in 1999, 62 persons with WNV illness, including seven deaths, were detected in New York City (NYC) and nearby New York counties. In 2000, these jurisdictions implemented active surveillance (AS) and enhanced passive surveillance (EPS) to detect human illness; 21 persons were identified with acute WNV infection (14 in New York, six in New Jersey, and one in Connecticut), including two deaths (one each in New York and New Jersey). This report summarizes the human WNV surveillance systems in Connecticut, New Jersey, New York, and NYC and recommends EPS for hospitalized patients with encephalitis of unknown etiology for the continental United States.

Entities:  

Mesh:

Year:  2001        PMID: 11411831

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

1.  Widespread West Nile virus activity, eastern United States, 2000.

Authors:  A A Marfin; L R Petersen; M Eidson; J Miller; J Hadler; C Farello; B Werner; G L Campbell; M Layton; P Smith; E Bresnitz; M Cartter; J Scaletta; G Obiri; M Bunning; R C Craven; J T Roehrig; K G Julian; S R Hinten; D J Gubler
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

Review 2.  The global ecology and epidemiology of West Nile virus.

Authors:  Caren Chancey; Andriyan Grinev; Evgeniya Volkova; Maria Rios
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

Review 3.  Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility.

Authors:  Aaron C Brault
Journal:  Vet Res       Date:  2009-05-01       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.